FindTrial
Sign In

High HDL cholesterol and ASCVD risk score

High HDL cholesterol and athersclerotic cardiovascular risk score

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/12/022320
Enrollment
210
Registered
2019-12-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E789- Disorder of lipoprotein metabolism, unspecified Health Condition 2: E789- Disorder of lipoprotein metabolism, unspecified

Interventions

None listed

Sponsors

Kasturba Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients in the age-group 18.00 years -75 years of both sexes and who are willing to give consent will be included. High HDL cholesterol will be taken as >50mg/dl in male, > 60mg/dl in females Age and sex matched controls with normal HDL cholesterol will be taken

Exclusion criteria

Exclusion criteria: Patient on high intensity exercise Cholesterol lowering diet Uncontrolled diabetes mellitus ( FBS > 200mg/dl, PPBS > 250mg/dl, HbA1C >8%- any one) Hypothyroidism (TSH >10 ) • Major organ dysfunction including liver and kidney ( including nephrotic syndrome) Sepsis Clinical evidence of Malignancy Steroid usage, OCPs and hormonal supplements High risk groups ( pregnant, retro positive patients)

Design outcomes

Primary

MeasureTime frame
1) We will know if high HDL cholesterol is beneficial in terms of decreasing ASCVD risk score. 2) Know the lifestyle of the subjects with high HDL cholesterol and its benefits Timepoint: 2 years—

Secondary

MeasureTime frame
To find out populations with CETP deficiency and their ASCVD riskTimepoint: 2 years—

Countries

India

Contacts

Public ContactUdupi Raksha Mallya

Kasturba Medical College

vsagar33@yahoo.com9880083580

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026